Joshua J. Short, Ph.D.
Affiliations: | 2004 | University of Alabama, Birmingham, Birmingham, AL, United States | |
2013-2015 | Pediatric Surgery | Mott Children's Hospital, Ann Arbor, MI, United States | |
2015- | Pediatric Surgery | Children's Hospitals of Minnesota, Saint Paul, MN, United States |
Google:
"Joshua Short"Mean distance: 22.94 (cluster 59)
Parents
Sign in to add mentorDavid T. Curiel | grad student | 2004 | UAB | |
(Identification and characterization of adenovirus serotype 3 primary cellular attachment receptors.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Short JJ, Rivera AA, Wu H, et al. (2010) Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy. Molecular Cancer Therapeutics. 9: 2536-44 |
Short JJ, Curiel DT. (2009) Oncolytic adenoviruses targeted to cancer stem cells. Molecular Cancer Therapeutics. 8: 2096-102 |
Short JJ, Vasu C, Holterman MJ, et al. (2006) Members of adenovirus species B utilize CD80 and CD86 as cellular attachment receptors. Virus Research. 122: 144-53 |
Short JJ, Pereboev AV, Kawakami Y, et al. (2004) Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors. Virology. 322: 349-59 |
Short JJ, Pereboev AV, Kawakami Y, et al. (2004) 116. Members of Adenovirus Subgroup B Utilize CD80 (B7.1) and CD86 (B7.2) as Primary Cellular Attachment Receptors Molecular Therapy. 9 |
Takayama K, Reynolds PN, Short JJ, et al. (2003) A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropism. Virology. 309: 282-93 |